10:58 IST
BSE
Other Announcement
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ended March 31, 2026, in compliance with SEBI regulations.
Bal Pharma Ltd
- Share price
- ₹99.80
- Market cap
- ₹158.9 Cr
- Revenue (annual)
- ₹311.7 Cr
- Net profit (annual)
- ₹6.28 Cr
- P/E (TTM)
- 22.1×Sector 47.4×
- Promoter holding
- 50.86%+0.00% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Annual General Meeting 7Other Announcement 6Management Change 4Financial Results 3Capital Structure Change 3Dividend 2Board Meeting Date 2Price Movement Clarification 1Merger & Restructuring 1Legal & Regulatory 1Fund Raise 1Annual Report 1
Time
6 announcements with these filters
13:34 IST
BSE
Other Announcement
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ending December 31, 2025. This disclosure provides details on share distribution among promoters and public.
17:13 IST
BSE
Other Announcement
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ending June 30, 2026, as required by SEBI regulations.
12:44 IST
BSE
Other Announcement
Bal Pharma Other Announcement
BAL PHARMA Ltd filed its quarterly shareholding pattern for Q2 FY2026. The filing details promoter and shareholder holdings without any monetary transaction.
16:19 IST
NSE
Other Announcement
Bal Pharma Other Announcement
Bal Pharma Limited submitted a compliance certificate for the quarter ended March 31, 2026, confirming the maintenance of a Structured Digital Database (SDD). The company certified that the database is non-tamperable, captures UPSI events, and maintains audit trails. This routine filing indicates full compliance with SEBI Prohibition of Insider Trading Regulations.
12:41 IST
BSE
Other Announcement
Bal Pharma Other Announcement
Bal Pharma Ltd has submitted its quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The company confirmed that share certificates received for dematerialization were processed and depository records updated within the prescribed 15-day limit.